Unknown

Dataset Information

0

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.


ABSTRACT: The aim of this study was to investigate the polymorphism frequency of plasminogen activator inhibitor-1 (PAI-1) (rs1799889) 4G/5G in patients with lung cancer.In this study, 286 genomic DNAs (154 lung cancer patients+132 subjects without lung cancer) were analyzed. Polymorphisms were determined by using the polymerase chain reaction (PCR) method, with 4G and 5G allele-specific primers. PCR products were assessed by a charge-coupled device camera and exposed to 2% agarose gel electrophoresis.The frequencies of the PAI-1 gene 4G/5G genotypes were found to be 21% 4G/4G, 16% 4G/5G, and 62% 5G/5G in the control group and 31.4% 4G/4G, 30.8% 4G/5G, and 37.8% 5G/5G in the patient group. It was determined that the 5G/5G genotype frequency was high in patients in comparison with other genotypes.This study found a statistically significant difference between the groups with respect to genotype distribution. Consequently, we can say that the PAI-1 gene 4G/5G polymorphism is associated with lung cancer in Turkey.

SUBMITTER: Bayramoglu A 

PROVIDER: S-EPMC4120932 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.

Bayramoglu Aysegul A   Gunes Hasan Veysi HV   Metintas Muzaffer M   Degirmenci Irfan I   Guler Halil Ibrahim HI   Ustuner Cengiz C   Musmul Ahmet A  

Genetic testing and molecular biomarkers 20140623 8


<h4>Aim</h4>The aim of this study was to investigate the polymorphism frequency of plasminogen activator inhibitor-1 (PAI-1) (rs1799889) 4G/5G in patients with lung cancer.<h4>Methods</h4>In this study, 286 genomic DNAs (154 lung cancer patients+132 subjects without lung cancer) were analyzed. Polymorphisms were determined by using the polymerase chain reaction (PCR) method, with 4G and 5G allele-specific primers. PCR products were assessed by a charge-coupled device camera and exposed to 2% aga  ...[more]

Similar Datasets

| S-EPMC4556460 | biostudies-literature
| S-EPMC3336151 | biostudies-literature
| S-EPMC5029677 | biostudies-literature
| S-EPMC5685717 | biostudies-literature
| S-EPMC7839372 | biostudies-literature
| S-EPMC4016530 | biostudies-literature
| S-EPMC3044959 | biostudies-literature
| S-EPMC7810990 | biostudies-literature
| S-EPMC4259258 | biostudies-literature
| S-EPMC5428408 | biostudies-literature